Foresite Capital Management III’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $11.4M | Hold |
1,111,112
| – | – | 29.98% | 2 |
|
|
2022
Q2 | $4.66M | Hold |
1,111,112
| – | – | 16.89% | 4 |
|
|
2022
Q1 | $5.54M | Hold |
1,111,112
| – | – | 16.89% | 3 |
|
|
2021
Q4 | $7.47M | Hold |
1,111,112
| – | – | 18.9% | 3 |
|
|
2021
Q3 | $6.09M | Hold |
1,111,112
| – | – | 8.44% | 3 |
|
|
2021
Q2 | $7.27M | Hold |
1,111,112
| – | – | 7.7% | 6 |
|
|
2021
Q1 | $9.29M | Buy |
+1,111,112
| New | +$9.29M | 8.16% | 5 |
|
|
2020
Q4 | – | Sell |
-1,111,112
| Closed | -$6.93M | – | 9 |
|
|
2020
Q3 | $6.93M | Buy |
+1,111,112
| New | +$6.93M | 5.16% | 8 |
|
|
2019
Q1 | – | Sell |
-206,663
| Closed | -$1.99M | – | 22 |
|
|
2018
Q4 | $1.99M | Sell |
206,663
-294,220
| -59% | -$2.84M | 0.65% | 21 |
|
|
2018
Q3 | $6.27M | Sell |
500,883
-1,942
| -0.4% | -$24.3K | 1.38% | 16 |
|
|
2018
Q2 | $6.87M | Sell |
502,825
-62,467
| -11% | -$853K | 1.48% | 15 |
|
|
2018
Q1 | $11.3M | Buy |
565,292
+36,870
| +7% | +$737K | 2.46% | 12 |
|
|
2017
Q4 | $6.27M | Sell |
528,422
-80,429
| -13% | -$955K | 1.76% | 11 |
|
|
2017
Q3 | $9.35M | Sell |
608,851
-4,750
| -0.8% | -$72.9K | 2.57% | 12 |
|
|
2017
Q2 | $7.15M | Buy |
+613,601
| New | +$7.15M | 2.34% | 12 |
|